ArticleDigestive diseases and sciences2026
Transient C1-Inhibitor Functional Abnormalities During Acute Idiopathic Pancreatitis: A Diagnostic Challenge in Hereditary Angioedema Evaluation.
Article in Digestive diseases and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeHereditary angioedema (HAE) is an important but uncommon differential diagnosis in patients presenting with unexplained recurrent abdominal attacks, including idiopathic acute pancreatitis (IAP). However, whether acute IAP itself transiently affects complement test results and complicates the evaluation of HAE remains unclear. This prospective study investigated changes in C1-inhibitor (C1-INH) function and complement parameters during acute IAP and after clinical recovery.
methodsIn this prospective observational study, 54 adult patients diagnosed with IAP according to the revised Atlanta criteria were initially enrolled. Three patients with incomplete baseline complement measurements were excluded from the longitudinal analysis, resulting in a final analytic cohort of 51 patients. Serum C4, C1-inhibitor antigenic level, C1-inhibitor functional activity, and C1q levels were measured during the acute-phase episode. Patients with abnormal complement parameters underwent repeat testing 8 weeks after clinical recovery.
resultsFour patients (7.8%) demonstrated reduced C1-inhibitor functional activity, and one patient (2.0%) had a reduced C1q level during the acute episode. All abnormal complement parameters in patients who underwent follow-up testing normalized at 8 weeks. No persistent C1-inhibitor deficiency or persistently reduced C1q levels were identified after recovery. Patients with transient complement abnormalities showed no distinctive biochemical features compared with the remaining cohort.
conclusionTransient abnormalities in C1-inhibitor functional activity and C1q may occur during IAP attacks and resolve after recovery. These findings suggest that complement test results obtained during an acute-phase pancreatitis episode should be interpreted cautiously when evaluating patients for hereditary angioedema. When HAE is clinically suspected, abnormal complement results should be confirmed after clinical remission before establishing a diagnosis of C1-inhibitor deficiency.
Indexed as
Identifiers
42649349What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.